We are preparing, please wait
Undervalued or Overvalued?
Unfortunately, this content is only accessible to registered users
Login to ContinueKey stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Market Cap
$12.20 M
Change
-$0
EPS
-$3.32
P/E Growth
-0.51
An income statement known as a profit and loss statement, is a financial report that summarizes a company's revenues, expenses, gains, and losses over a specific period. It provides insight into a company's operational efficiency and profitability, helping investors and stakeholders assess financial performance and make informed decisions.
The Financials Balance Sheet report provides a clear and concise visual summary of a company’s financial standing through interactive charts. This section highlights key components such as assets, liabilities, and equity, offering investors an at-a-glance understanding of the company's financial health. By showcasing these critical metrics in an easy-to-digest format, the report enables stakeholders to evaluate the company’s stability, operational efficiency, and capital structure, fostering more informed investment decisions.
The Financials Cash Flow report uses charts to provide a clear breakdown of a company’s cash flow across operating, investing, and financing activities. This visualization helps investors quickly assess how the company generates, spends, and manages cash, offering valuable insights into its liquidity and financial efficiency.
The latest Technical Analysis Summary on Stocks.News offers insights into market trends using key Technical Indicators like RSI and MACD, alongside Moving Averages such as the 50-day and 200-day. The analysis identifies buy and sell signals through bullish or bearish crossovers, helping investors make informed trading decisions.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
Today's price of Inhibikase Therapeutics, Inc. is $2.96 — it has decreased by 0% in the past 24 hours. Watch Inhibikase Therapeutics, Inc. stock price performance more closely on the chart.
Yes, you can track Inhibikase Therapeutics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.
Watch the Inhibikase Therapeutics, Inc. chart and read a more detailed Inhibikase Therapeutics, Inc. stock forecast to see what analysts suggest you do with its shares.
The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Inhibikase Therapeutics, Inc. stock ticker.
Like other stocks, IKT shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.
Inhibikase Therapeutics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Inhibikase Therapeutics, Inc.’s financial statements.
